The strong sales growth, particularly in the key China market, suggests robust demand and effective inventory normalization. Traders should monitor the full earnings release in early May for confirmation of adjusted EBITDA improvement and any guidance implications, while remaining cautious about risks in geopolitically challenged regions.
Price Chart
Executive Summary
STAAR Surgical reported preliminary Q1 2026 net sales exceeding $90 million, more than double the $42.6 million from Q1 2025, driven by strong performance in China and the Americas. The company expects improved adjusted EBITDA but notes geopolitical challenges in parts of EMEA and APAC.
Key Facts
- Preliminary net sales for Q1 2026 exceeded $90 million
- Q1 2025 net sales were $42.6 million
- Strong growth driven by China, which accounted for the majority of the increase, and continued double-digit growth in the Americas
- Geopolitical and macroeconomic challenges negatively affected sales in parts of the Middle East, EMEA, and APAC
- Distributor inventory in China is now within targeted range after prior supply adjustments
Financial Impact
Net sales more than doubled year-over-year, from $42.6M to over $90M, with expected meaningful improvement in adjusted EBITDA
Risk Factors
- Geopolitical and macroeconomic challenges in Middle East, EMEA, and APAC regions could continue to negatively impact sales
- The financial information is preliminary and unaudited, subject to adjustment upon final review
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000718937-26-000009 |
| Document: staa-ex99_1.htm | 0000718937-26-000009 |
| Document: 0000718937-26-000009-index-headers.html | 0000718937-26-000009 |
| Document: 0000718937-26-000009-index.html | 0000718937-26-000009 |
| Document: 0000718937-26-000009.txt | 0000718937-26-000009 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 10w ago | 8-K | $25.33 | awaiting T+60 | — | $23.23 (−8.29%) |
Aug 6, 2026 11w ago | 8-K | $23.12 | awaiting T+60 | — | $23.23 (+0.48%) |
Jun 22, 2026 18w ago | 8-K | $28.36 $22.41 | ▼ −20.98% | ▼ −24.23% | $23.23 (−18.09%) |
Jun 11, 2026 19w ago | Institutional Cluster | $28.90 $23.47 | ▲ +18.79% | ▲ +23.18% | $23.23 (+19.62%) |
May 13, 2026 23w ago | 8-K | $32.01 $25.12 | ▼ −21.52% | ▼ −25.11% | $23.23 (−27.43%) |
Apr 8, 2026 28w ago | 8-K | $25.21 $27.34 | ▲ +8.45% | ▼ −2.33% | $23.23 (−7.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers